HLA Typing Market to Surpass USD 2.50 Billion by 2030 on Account of Increasing Prevalence of Immune-Related Disorders and Technological Advancements in HLA Typing | Research by SNS Insider

According to SNS Insider, key players in the HLA typing market are increasingly engaging in collaborations and strategic partnerships to accelerate research and development activities. Collaborations between academic institutions, diagnostic companies, and pharmaceutical firms have led to the discovery of novel HLA associations with various diseases and the development of targeted therapies. These collaborative efforts have contributed significantly to the growth of the market by fostering innovation and knowledge exchange.

1401 Lavaca ST 800, Austin Tx 78701


Pune, Aug. 03, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that the HLA Typing Market was valued at US$ 1.5 billion in 2022 and is projected to reach US$ 2.50 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030.”

HLA Typing Market Overview:

HLA typing plays a vital role in understanding the genetic identity of immunity and its implications in various medical fields. With advances in technology and the availability of high-resolution methods like NGS, HLA typing continues to contribute significantly to personalized medicine, transplantation success, disease risk assessment, and understanding human population genetics.

Market Analysis

The HLA typing market is poised for significant growth, driven by technological advancements, the increasing prevalence of immune-related disorders, and the expanding applications in transplantation medicine and personalized cancer immunotherapies. As precision medicine continues to gain momentum, HLA typing will remain a critical component in disease diagnosis, treatment selection, and patient outcomes. The integration of state-of-the-art technologies, along with collaborative research initiatives, will pave the way for a promising future in the realm of HLA typing, transforming the landscape of healthcare worldwide.

Major Players Included in this Report are:

The Key players are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, Pacific Biosciences, and other players

Get a Sample Report of HLA Typing Market @ https://www.snsinsider.com/sample-request/3176

Impact of Recession on HLA Typing Market Growth

While a recession can pose significant challenges for the HLA typing market, it also presents opportunities for innovation, collaboration, and market adaptation. By navigating through these difficult times with strategic planning and flexibility, the HLA typing industry can continue to contribute significantly to the advancement of healthcare and patient well-being.

Impact of the Russia-Ukraine War

The Russia-Ukraine War has significantly impacted the HLA typing market, presenting both challenges and opportunities. Disruptions in research, supply chains, and regional markets have required the industry to adapt and innovate. However, increased global investment, diversification of supply chains, and initiatives to improve accessibility are reshaping the HLA typing landscape for the better.

HLA Typing Market Report Scope:

Report Attributes Details
 Market Size in 2022  US$ 1.5 Bn
 Market Size by 2030  US$ 2.50 Bn
 CAGR  CAGR of 6.6 % From 2023 to 2030
 Base Year  2022
 Forecast Period  2023-2030
 Historical Data  2020-2021
HLA Typing Market: Key Segmentation • By Product (Instruments, Reagents & Consumables, Software & Services)
• By Application (Diagnosis, Research)
• By Technique (Molecular Assay, Sequenced-based Molecular Assay, Non-Molecular Assay)
• By End-user (Commercial Service Providers, Hospitals and Transplant Centers, Research Labs & Academic Institutes)
 Key Regional Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Get an Excel-Data Sheet of HLA Typing Market with Detailed Analysis (Sheet Included Market Size & Share of Regions, Countries, and Continents Data)  Get Excel-Data Sheet Here

Key Regional Developments

The global HLA typing market continues to witness significant growth due to increasing demand for organ transplantation, rising prevalence of autoimmune diseases, and the emergence of personalized medicine. Regional dynamics play a crucial role in shaping the market landscape, with North America and Europe leading in terms of technology adoption and research initiatives. Meanwhile, the Asia Pacific region is becoming a lucrative market, driven by a rising geriatric population and improvements in healthcare infrastructure.

Key Takeaway from HLA Typing Market Study

  • As the market continues to expand, the Instruments segment and Retail & Commercial Service Providers are expected to play key roles in shaping its trajectory. Advancements in instrument technology, such as high-throughput systems and NGS platforms, will bolster accuracy and efficiency in HLA typing.
  • Simultaneously, Retail & Commercial Service Providers' focus on customer-centric solutions and customized testing panels will facilitate research and clinical advancements, driving the growth of the global market in the years to come.

Recent Developments Related to HLA Typing Market

  • Metropolis Healthcare Limited, a global leader in diagnostic services, has once again set a new standard in transplant medicine with the launch of their cutting-edge 'NextGen HLA' High-Resolution Typing Test. The 'NextGen HLA' test utilizes state-of-the-art genomic sequencing and bioinformatics technology, enabling unparalleled precision and resolution in HLA typing.
  • CareDx, a leading precision medicine company focused on transplant diagnostics, unveiled its latest breakthroughs and advancements across the AlloSeq Lab Products portfolio during the 36th European Immunogenetics Conference.

Table of Contents

1. Introduction

2. Research Methodology

3. Market Dynamics

4. Impact Analysis

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. HLA Typing Market, By Product

9. HLA Typing Market, By Application

10. HLA Typing Market, By Technique

11. HLA Typing Market, By End-user

12. Regional Analysis

13. Company Profile

14. Competitive Landscape

15. USE Cases and Best Practices

16. Conclusion

Buy Single-User PDF of the HLA Typing Market Report @ https://www.snsinsider.com/checkout/3176

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominate the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Access Complete Report Details@ https://www.snsinsider.com/reports/hla-typing-market-3176

 

Kontaktdaten